Bank of the James Financial Group, Inc. to Present at the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Bank of the James Financial Group, Inc. to Present at the Raymond James 2016 U.S. Bank Conference

LYNCHBURG, Va., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Bank of the James Financial Group, Inc. (NASDAQ: BOTJ ), the parent company of Bank of the James, a full-service commercial and retail bank serving the Greater Lynchburg MSA, commonly known as “Region 2000” and other markets in Central Virginia, will be presenting to investors at the Raymond James 2016 U.S. Bank Conference September 7, 2016 in Chicago, Illinois.

The company will be represented at the conference by Robert R. Chapman III, President and CEO, J. Todd Scruggs, EVP and Chief Financial Officer, Michael A. Syrek, EVP and Chief Lending Officer, and Harry P. Umberger, EVP and Chief Credit Officer.

Bank of the James Financial Group, Inc. posted record assets and loans at June 30, 2016, and also record second quarter earnings for the three months ended June 30, 2016. The company was ranked among the top 200 performing community banks and thrifts in the nation by American Banker magazine in May 2016. The Top 200 Ranking was based upon the three-year average Return on Equity for the years 2013-2015 and included banks and thrifts with less than $2 billion in total assets as of December 31, 2015.

A copy of the company’s investor presentation will be available on the bank’s website following the presentation.

About the Company Bank of the James Financial Group, Inc. is a bank holding company with $545.73 million in total assets as of June 30, 2016 and trades on the NASDAQ Capital Market, LLC under the symbol “BOTJ”.  Bank of the James, a wholly owned subsidiary of Bank of the James Financial Group, Inc. serves the greater Lynchburg, Virginia MSA, often referred to as Region 2000, and other markets including Charlottesville, Harrisonburg and Roanoke in Virginia. The bank operates ten full service locations, two limited service branches, two loan production offices, and an investment/insurance services division.

Contact:  J. Todd Scruggs, EVP and Chief Financial Officer tscruggs@bankofthejames.com (434) 455-7511

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Valour Inc. Unveils Advanced Leveraged ETPs for Crypto Trading

Updated Category News Views 86

Valour Inc. Launches Innovative Leveraged ETPs Valour Inc., a subsidiary of DeFi Technologies, is making waves in the financial technology sector by launching leveraged exchange-traded products (ETPs) focused on Bitcoin and Ethereum. These new offerings, titled Bull Bitcoin X2 Valour and Bull Ethereum X2 Valour, deliver twice the daily exposure to these leading...

Continue Reading
Inhibikase Therapeutics Makes Headway with $275 Million Financing

Updated Category News Views 84

Introduction to Inhibikase Therapeutics Inhibikase Therapeutics, Inc. (NASDAQ: IKT) is a pioneering clinical-stage pharmaceutical company dedicated to creating innovative therapeutics for cardiopulmonary and neurodegenerative diseases. Their commitment to developing high-quality treatments is evident in the recent announcement regarding an impressive financing deal....

Continue Reading
JBS USA Food Company's Successful Tender Offer for Notes

Updated Category News Views 341

Overview of the Tender Offer by JBS USA Food Company JBS USA Food Company recently shared exciting news about the successful conclusion of its cash tender offer for its 2.500% Senior Notes due 2027. The offer was designed for any and all outstanding notes, aimed at strengthening the company's financial position. Details on Tender Offer Results As reported, the results...

Continue Reading
Imaflex's Impressive Q2 2025 Results Show Resilience

Updated Category News Views 114

Strong Balance Sheet and Operational Agility Support Future Growth In a world where market dynamics can shift unexpectedly, Imaflex Inc. is finding ways to maintain robust performance despite the prevailing challenges. The company recently released its financial results for the second quarter of 2025 with notable highlights that showcase its resilience and strategic...

Continue Reading
A Decade of Growth: The Journey of Penumbra Stock Value

Updated Category News Views 158

Understanding Penumbra's Growth Over the Last Decade Penumbra (NYSE: PEN) has shown remarkable growth over the past decade, achieving an annualized return of 20.49%. This performance eclipses the market by an impressive 7.83% annually, making it a notable player in the healthcare sector. The Impact of Compounding Returns When it comes to investing, one fundamental...

Continue Reading